04/19/2022
GOING WITH A GUT FEELING
By Lake County Partners, Date: April 19, 2022
click the link below to read the full article...
https://www.lakecountypartners.com/going-with-a-gut-feeling/
THE CASE OF COVIRA
Covira is a biotech company spun out from the University of Chicago that develops drugs to modulate the gut microbiome. Its lead asset is focused on the prevention of post-surgical infections. Covira is productively using its time at Helix 51 to prepare for its next capital raise of $15 million needed to complete Phase 1 and Phase 2 of human clinical trials. The company projects that the FDA approval process could take 4 – 5 years to complete.
“We are really at the cutting-edge of microbiome research, and our work stands to prevent both the incidence and progression of post-surgical infection and its subsequent development of disability and mortality. Our team is led by Dr. John Alverdy, MD, a world authority in this field whose knowledge led us to be named one of the top twenty most innovative companies by Business Worldwide Magazine,” said Covira Surgical CEO Peter Farmakis. “We chose Helix 51 because we know that Lake County is the heart of the nation’s life science corridor. Here, we will be able to find the additional talent and investors that we need to successfully achieve Covira’s growth objectives.”
..to read the full article click the link below
https://www.lakecountypartners.com/going-with-a-gut-feeling/
When the Chicago Tribune recently asked Congressman Brad Schneider to comment on the wave of biotech startups growing at Rosalind Franklin University’s Helix 51 incubator, he called Lake County “the home of the nation’s life ... Read More
